“…The development of chronic arthritis, after systemic injection of an aqueous suspension of SCW PG‐PS fragments, appears to depend upon the capacity of the fragments (1) to deposit in joint tissues; (2) to persist in tissues, including the joints, for prolonged periods of time; and (3) to stimulate macrophage and T cell–dependent proinflammatory mechanisms in the joints (Abd et al, ; Allen et al, ; Anderle et al, ; Bristol et al, ; Case et al, ; Schwab and Smialowicz, ; Van Den Broek et al, , ; Wilder et al, ; Yocum et al, ; Yoshino et al, ). Arthritogencity of Group A SCW PG‐PS fragments is also strongly affected by their size distribution.…”